Claude Johns, CRNA | |
1725 Pine St, Montgomery, AL 36106-1109 | |
(334) 293-8000 | |
Not Available |
Full Name | Claude Johns |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 42 Years |
Location | 1725 Pine St, Montgomery, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669439253 | NPI | - | NPPES |
000008419 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 071909 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Jackson Hospital & Clinic Inc | Montgomery, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Montgomery Anesthesia Associates, Pc | 9537153572 | 48 |
News Archive
The American Society for Aesthetic Plastic Surgery (ASAPS) announces today its support of a new national registry for breast implants that will be compiled by the American Society of Plastic Surgeons (ASPS) in collaboration with the Food and Drug Administration (FDA). This registry will document reported cases of a very rare condition, Anaplastic Large Cell Lymphoma (ALCL), in the presence of breast implants.
NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels, Belgium.
Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.
AdverseEvents Inc., a leading healthcare informatics company, today launched RxCost, the first methodology to identify the total costs of adverse drug reactions (ADRs) associated with FDA-approved drugs.
› Verified 5 days ago
Entity Name | Montgomery Anesthesia Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043281553 PECOS PAC ID: 9537153572 Enrollment ID: O20040412001708 |
News Archive
The American Society for Aesthetic Plastic Surgery (ASAPS) announces today its support of a new national registry for breast implants that will be compiled by the American Society of Plastic Surgeons (ASPS) in collaboration with the Food and Drug Administration (FDA). This registry will document reported cases of a very rare condition, Anaplastic Large Cell Lymphoma (ALCL), in the presence of breast implants.
NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels, Belgium.
Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.
AdverseEvents Inc., a leading healthcare informatics company, today launched RxCost, the first methodology to identify the total costs of adverse drug reactions (ADRs) associated with FDA-approved drugs.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Claude Johns, CRNA Po Box 235019, Montgomery, AL 36123-5019 Ph: (334) 279-1450 | Claude Johns, CRNA 1725 Pine St, Montgomery, AL 36106-1109 Ph: (334) 293-8000 |
News Archive
The American Society for Aesthetic Plastic Surgery (ASAPS) announces today its support of a new national registry for breast implants that will be compiled by the American Society of Plastic Surgeons (ASPS) in collaboration with the Food and Drug Administration (FDA). This registry will document reported cases of a very rare condition, Anaplastic Large Cell Lymphoma (ALCL), in the presence of breast implants.
NanoBio Corporation announced today that its CEO and Founder, James R. Baker, Jr., M.D., will present new data from studies of its nanoemulsion-based adjuvant platform during the World Influenza Congress, taking place from December 7-9, 2009 in Brussels, Belgium.
Hokkaido University scientists have shown that Interleukin-34 is a prognostic marker and drug target for Triple Negative Breast Cancer.
AdverseEvents Inc., a leading healthcare informatics company, today launched RxCost, the first methodology to identify the total costs of adverse drug reactions (ADRs) associated with FDA-approved drugs.
› Verified 5 days ago
Mrs. Amanda Marie Haigler, DNP CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8000 | |
Crista Wanda Marquardt, C.R.N.A. Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-288-2100 | |
Andrew Easterling, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-279-1450 Fax: 334-395-4115 | |
James Cowell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1725 Pine St, Montgomery, AL 36106 Phone: 334-293-8000 | |
Thomas H. Booth Ii, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-386-3579 | |
Susan Hamilton Mitchell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Montgomery, AL 36116 Phone: 334-288-2100 | |
Hollie Nicole Sanders, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2105 E South Blvd, Baptist Hospital Dept Of Anes, Montgomery, AL 36116 Phone: 770-643-5619 |